Clinical Trial Update: Anaemetro I.V. Infusion 500mg Drug Use Investigation

View source ↗

Summary

A completed Pfizer-sponsored trial investigating Anaemetro IV infusion 500mg for anaerobic infection and infectious enterocolitis with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amebic Dysentery
• Anaerobic Infection
• Infectious Enterocolitis

Drugs mentioned

• Anaemetro ( Anaemetro)

Snippet

Sponsor: Pfizer | Conditions: Anaerobic Infection, Infectious Enterocolitis | Status: COMPLETED | Results posted: 2018-12-28